Hainan Kelaiwei Pharmaceutical

Hainan Kelaiwei Pharmaceutical is a specialized pharmaceutical company based in Haikou, China, and serves as a key subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited (Grand Pharma). The company is primarily focused on the ophthalmology and ENT therapeutic areas, managing a portfolio of commercialized products including ophthalmic solutions for allergic conjunctivitis and bacterial infections. Hainan Kelaiwei plays a significant role in the manufacturing and distribution of Grand Pharma's specialized drug products within the Chinese market. Its operations are integrated into the broader Grand Pharma ecosystem, which emphasizes innovative R&D in precision intervention and specialized medicines. Key products in its portfolio include Pemirolast Potassium and Gatifloxacin eye drops, which are widely used in clinical practice across China.